William Blair Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-147,819
Closed -$9.06M 436
2017
Q4
$9.06M Sell
147,819
-171,061
-54% -$10.7M 0.04% 304
2017
Q3
$20.3M Sell
318,880
-4,400
-1% -$257K 0.07% 248
2017
Q2
$18M Sell
323,280
-1,387,641
-81% -$75.5M 0.07% 264
2017
Q1
$93M Sell
1,710,921
-453,201
-21% -$24.9M 0.35% 93
2016
Q4
$126M Sell
2,164,122
-602,460
-22% -$32.9M 0.51% 66
2016
Q3
$149M Sell
2,766,582
-278,862
-9% -$17.9M 0.56% 57
2016
Q2
$224M Sell
3,045,444
-123,873
-4% -$8.75M 0.89% 31
2016
Q1
$202M Buy
3,169,317
+39,611
+1% +$2.5M 0.8% 38
2015
Q4
$215M Buy
3,129,706
+424,364
+16% +$28M 0.87% 31
2015
Q3
$160M Buy
+2,705,342
New +$172M 0.33% 93

Other funds holding BMY

William Blair Investment Management's BMY Position: Q1 2018 in Review

William Blair Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 147,819 shares — an estimated $9.06M sold.

William Blair Investment Management first reported a position in BMY in Q3 2015 and held it in 10 quarters. The position peaked at $224M in Q2 2016. 1,747 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

  • William Blair Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
  • William Blair Investment Management sold 147,819 Bristol-Myers Squibb shares in Q1 2018, an estimated $9.06M.
  • William Blair Investment Management first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 10 quarters.
  • William Blair Investment Management's Bristol-Myers Squibb position peaked at $224M in Q2 2016.
  • 1,747 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on William Blair Investment Management's 13F filing for Q1 2018, filed 14 May 2018.